Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Mercury Laboratories Ltd
Your Vote -
Buy
33.33%
Hold
33.33%
Sell
33.33%
33.33%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Mercury Laboratories Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Mercury Laboratories - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
-
Mercury Laboratories - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Mercury Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
-
Mercury Laboratories - Disclosure Under Regulation 30 Of The SEBI (LODR) Reg, 2015- Imposition Of Penalty
-
Mercury Laboratories - Change In Email Address Of RTA MUFG Intime India Pvt Ltd
-
Mercury Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Mercury Laboratories - Announcement under Regulation 30 (LODR)-Change in Management
-
Mercury Laboratories Q3 net profit down 4.03% at Rs 1.19 cr
-
Mercury Laboratories - Integrated Filing (Financial)
-
Mercury Laboratories - Results-Financial Results For Quarter And Nine Months Ended On December 31, 2024
-
Mercury Laboratories - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended On Decembe
-
Mercury Laboratories - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months E
Key fundamentals
Evaluate the intrinsic value of Mercury Laboratories Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 56.3341 | 50.9931 | 45.4082 | 43.1344 | 38.3031 |
| Liabilities | 56.3341 | 50.9931 | 45.4082 | 43.1344 | 38.3031 |
| Equity | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| Gross Profit | 9.0303 | 8.5705 | 7.1145 | 9.5907 | 6.1658 |
| Net Profit | 5.6542 | 5.5788 | 3.6862 | 5.3374 | 3.2281 |
| Cash From Operating Activities | 8.225 | 2.4524 | 5.1505 | 8.2138 | 5.4924 |
| NPM(%) | 7.48 | 7.4 | 6.36 | 7.78 | 5.63 |
| Revenue | 75.559 | 75.3337 | 57.9238 | 68.6014 | 57.2691 |
| Expenses | 66.5287 | 66.7632 | 50.8093 | 59.0107 | 51.1032 |
| ROE(%) | 11.12 | 10.97 | 7.25 | 10.49 | 6.34 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Mercury Laboratories Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 824.20 | -1.99 | 11.65 | 468.73 | 1321.50 | 1.39 |
| Lotus Eye Hospital and Institute Ltd | 80.41 | -0.74 | 338.42 | 1708.00 | 14.01 | 0.62 |
| Bharat Immunological and Biologicals Corporation Ltd | 23.00 | -1.41 | 0.00 | 3546.37 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 681.00 | -1.58 | 0.00 | 1610.50 | -687.11 | 0.00 |
Company Info
The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited. 2015 -Mercury Laboratories is been listed in BSE.
The Company was incorporated on 12.02.1982, under the name and style of Mercury Laboratories Pvt. Limited. The promoters of the Company were MR. Kantilal Bapulal Shah & Mr. Ramanlal Bapulal Shah. The objective of the company is to manufacture all types of pharmaceutical formulations in the form of tablets, capsules, liquid orals, Injectables and Ointments. The Company became a Public Ltd. company on 15th May 1992 and its name was then changed to Mercury Laboratories Limited. 2015 -Mercury Laboratories is been listed in BSE.
Read More
Parent Organisation
Mercury Laboratories Ltd.
Founded
12/02/1982
Managing Director
Mr.Rajendra R Shah
NSE Symbol
FAQ
The current price of Mercury Laboratories Ltd is
The 52-week high for Mercury Laboratories Ltd is
The market capitalization of Mercury Laboratories Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Mercury Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Mercury Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Mercury Laboratories Ltd shares.
The CEO of Mercury Laboratories Ltd is Mr.Rajendra R Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
